Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 24, 2007
Advances in the treatment of patients with gastric adenocarcinomaTheodoros Foukakis, Lars Lundell, Michael Gubanski, et al.
European Journal of Radiology|March 24, 2025
Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trialAthanasios Zouzos, Irma Fredriksson, Andreas Karakatsanis, et al.
Biomedicines|December 30, 2025
Variation in Pathological Appearance Across Repeated Sampling from Probably Benign Breast LesionsAthanasios Zouzos, Irma Fredriksson, Theodoros Foukakis, et al.
Critical Reviews in Oncology/Hematology|October 22, 2023
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic reviewPanagiotis Filis, Ioannis Zerdes, Theodora Soumala, et al.
Acta Oncologica (Stockholm, Sweden)|November 11, 2014
A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, SwedenLuisa Kessler, Claudette Falato, Sara Margolin, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Expert Discussion: HER2-Positive Breast CancerTheodoros Foukakis, Alexios Matikas, Olga Oikonomidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?Antroula Papakonstantinou, Theodoros Foukakis, Kenny A Rodriguez-Wallberg, et al.
Cancers|May 8, 2019
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer ImmunotherapySebastian Chrétien, Ioannis Zerdes, Jonas Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Reply to A.Y. LinAntroula Papakonstantinou, Theodoros Foukakis, Kenny A Rodriguez-Wallberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2025
Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based studyXingrong Liu, Louise Eriksson Bergman, Caroline Boman, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Acta Oncologica (Stockholm, Sweden)|April 24, 2007
Advances in the treatment of patients with gastric adenocarcinomaTheodoros Foukakis, Lars Lundell, Michael Gubanski, et al.
European Journal of Radiology|March 24, 2025
Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trialAthanasios Zouzos, Irma Fredriksson, Andreas Karakatsanis, et al.
Biomedicines|December 30, 2025
Variation in Pathological Appearance Across Repeated Sampling from Probably Benign Breast LesionsAthanasios Zouzos, Irma Fredriksson, Theodoros Foukakis, et al.
Critical Reviews in Oncology/Hematology|October 22, 2023
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic reviewPanagiotis Filis, Ioannis Zerdes, Theodora Soumala, et al.
Acta Oncologica (Stockholm, Sweden)|November 11, 2014
A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, SwedenLuisa Kessler, Claudette Falato, Sara Margolin, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Expert Discussion: HER2-Positive Breast CancerTheodoros Foukakis, Alexios Matikas, Olga Oikonomidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?Antroula Papakonstantinou, Theodoros Foukakis, Kenny A Rodriguez-Wallberg, et al.
Cancers|May 8, 2019
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer ImmunotherapySebastian Chrétien, Ioannis Zerdes, Jonas Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Reply to A.Y. LinAntroula Papakonstantinou, Theodoros Foukakis, Kenny A Rodriguez-Wallberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2025
Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based studyXingrong Liu, Louise Eriksson Bergman, Caroline Boman, et al.
Pageof 13